• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎中的弓形虫性脉络膜视网膜炎与抗肿瘤坏死因子治疗

Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis.

作者信息

Lassoued Slim, Zabraniecki Laurent, Marin Frédéric, Billey Thierry

机构信息

Service de Rhumatologie, Centre Hospitalier, Cahors, France.

出版信息

Semin Arthritis Rheum. 2007 Feb;36(4):262-3. doi: 10.1016/j.semarthrit.2006.08.004. Epub 2006 Oct 25.

DOI:10.1016/j.semarthrit.2006.08.004
PMID:17067660
Abstract

OBJECTIVES

To present the data supporting the possible relationship of ocular toxoplasmosis to antitumor necrosis factor-alpha (TNF-alpha) therapy in patients with rheumatoid arthritis (RA).

METHODS

A Medline search was performed using the words "toxoplasmosis, anti-TNF-alpha antagonists, chorioretinitis." We report 2 RA patients who developed ocular toxoplasmosis while receiving anti-TNF-alpha therapy.

RESULTS

In addition to our patients with toxoplasmic chorioretinitis, there are 2 published cases of cerebral toxoplasmosis during treatment with anti-TNF-alpha agents.

CONCLUSION

The risk of serious toxoplasmic infection during anti-TNF-alpha therapy for RA should be recognized.

摘要

目的

提供数据支持眼部弓形虫病与类风湿关节炎(RA)患者抗肿瘤坏死因子-α(TNF-α)治疗之间可能存在的关系。

方法

使用“弓形虫病、抗TNF-α拮抗剂、脉络膜视网膜炎”等词在医学文献数据库(Medline)中进行检索。我们报告了2例类风湿关节炎患者在接受抗TNF-α治疗期间发生眼部弓形虫病的病例。

结果

除了我们患有弓形虫性脉络膜视网膜炎的患者外,还有2例已发表的在用抗TNF-α药物治疗期间发生脑弓形虫病的病例。

结论

应认识到类风湿关节炎患者接受抗TNF-α治疗期间发生严重弓形虫感染的风险。

相似文献

1
Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis.类风湿关节炎中的弓形虫性脉络膜视网膜炎与抗肿瘤坏死因子治疗
Semin Arthritis Rheum. 2007 Feb;36(4):262-3. doi: 10.1016/j.semarthrit.2006.08.004. Epub 2006 Oct 25.
2
Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.抗肿瘤坏死因子治疗:以色列北部单一中心的6年经验及卫生政策对结果的可能影响。
Isr Med Assoc J. 2008 Apr;10(4):277-81.
3
Does anti-tumor necrosis factor-α therapy affect risk of serious infection and cancer in patients with rheumatoid arthritis?: a review of longterm data.抗肿瘤坏死因子-α 治疗是否会影响类风湿关节炎患者严重感染和癌症的风险?:长期数据回顾。
J Rheumatol. 2011 Aug;38(8):1552-62. doi: 10.3899/jrheum.100995. Epub 2011 May 15.
4
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.类风湿关节炎的抗肿瘤坏死因子治疗与恶性淋巴瘤风险:瑞典生物制剂登记处的相对风险和时间趋势
Ann Rheum Dis. 2009 May;68(5):648-53. doi: 10.1136/ard.2007.085852. Epub 2008 May 8.
5
Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.韩国类风湿关节炎(RA)患者的结核病发病率:RA本身及肿瘤坏死因子阻滞剂的影响
J Rheumatol. 2007 Apr;34(4):706-11. Epub 2007 Feb 15.
6
The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy: a review.抗TNF治疗期间银屑病及银屑病样皮损的神秘发展:综述
Semin Arthritis Rheum. 2008 Feb;37(4):251-5. doi: 10.1016/j.semarthrit.2007.05.004. Epub 2007 Jul 20.
7
The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.在89,710人年的观察期内,甲氨蝶呤和抗肿瘤坏死因子疗法对19,562例类风湿关节炎患者淋巴瘤风险的影响。
Arthritis Rheum. 2007 May;56(5):1433-9. doi: 10.1002/art.22579.
8
Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.类风湿关节炎患者使用英夫利昔单抗治疗的肺部并发症
J Rheumatol. 2006 Mar;33(3):622-8.
9
[Serious lung disease in RA and TNF-blockade--is there a connection?].[类风湿关节炎与肿瘤坏死因子阻断治疗中的严重肺部疾病——存在关联吗?]
Lakartidningen. 2006;103(5):308; author reply 308-9.
10
Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study.老年类风湿关节炎患者中抗肿瘤坏死因子α治疗的耐受性和有效性:一项基于人群的队列研究。
Arthritis Rheum. 2007 May 15;57(4):679-85. doi: 10.1002/art.22688.

引用本文的文献

1
Intraocular infections following biologicals and Janus Kinase inhibitors.生物制剂和 Janus 激酶抑制剂后的眼内感染
Indian J Ophthalmol. 2025 Aug 1;73(8):1091-1094. doi: 10.4103/IJO.IJO_1117_25. Epub 2025 Jul 28.
2
Fatal toxoplasmic encephalitis triggered by anti-TNF therapy.抗TNF治疗引发的致命性弓形虫脑炎。
Heliyon. 2025 Jan 21;11(3):e41965. doi: 10.1016/j.heliyon.2025.e41965. eCollection 2025 Feb 15.
3
Active toxoplasma chorioretinitis in immunocompromised patients: a case series.免疫功能低下患者的活动性弓形虫脉络膜视网膜炎:病例系列
Arch Clin Cases. 2024 Apr 17;11(1):5-12. doi: 10.22551/2024.42.1101.10278. eCollection 2024.
4
and seropositivity in juvenile idiopathic arthritis and its relation to disease activity and type of therapies.青少年特发性关节炎中的血清阳性及其与疾病活动度和治疗类型的关系。
Food Waterborne Parasitol. 2023 May 19;31:e00195. doi: 10.1016/j.fawpar.2023.e00195. eCollection 2023 Jun.
5
Toxoplasmosis in patients with an autoimmune disease and immunosuppressive agents: A multicenter study and literature review.自身免疫性疾病和免疫抑制剂治疗患者的弓形虫病:一项多中心研究和文献复习。
PLoS Negl Trop Dis. 2022 Aug 8;16(8):e0010691. doi: 10.1371/journal.pntd.0010691. eCollection 2022 Aug.
6
COVID-19-associated opportunistic infections: a snapshot on the current reports.COVID-19 相关机会性感染:当前报告简述。
Clin Exp Med. 2022 Aug;22(3):327-346. doi: 10.1007/s10238-021-00751-7. Epub 2021 Aug 23.
7
Ocular side effects of antirheumatic medications: a qualitative review.抗风湿药物的眼部副作用:一项定性综述
BMJ Open Ophthalmol. 2020 Jan 7;5(1):e000331. doi: 10.1136/bmjophth-2019-000331. eCollection 2020.
8
Toxoplasmosis in a patient receiving ixekizumab for psoriasis.一名接受司库奇尤单抗治疗银屑病的患者发生弓形虫病。
JAAD Case Rep. 2020 Feb 19;6(3):204-206. doi: 10.1016/j.jdcr.2020.01.005. eCollection 2020 Mar.
9
Toxoplasmosis in Germany.弓形虫病在德国。
Dtsch Arztebl Int. 2019 Jun 21;116(25):435-444. doi: 10.3238/arztebl.2019.0435.
10
Advances and Challenges in Understanding Cerebral Toxoplasmosis.脑弓形虫病的研究进展与挑战
Front Immunol. 2019 Feb 14;10:242. doi: 10.3389/fimmu.2019.00242. eCollection 2019.